The U.S. Centers for Disease Control and Prevention’s (CDC) advisory panel endorsed Moderna’s vaccine for children aged 6 to 17.
If the CDC signs off on the recommendation, it would mean both mRNA COVID-19 vaccines would be available to all Americans aged 6 months old and up.
Federal health officials in October signed off on emergency authorizations for Pfizer’s vaccine for children aged 5 to 11. And last week, officials gave emergency use authorizations for both Pfizer’s and Moderna’s COVID-19 vaccines for children aged 6 months to 4 years.
“We know that Covid can cause severe disease and death among children and adolescents, including those without underlying medical conditions,” said Dr. Sara Oliver, a CDC scientist, during the panel meeting.
“The benefits outweigh the risks for mRNA COVID-19 vaccines in all ages,” she claimed.
There have been concerns that the Moderna vaccine, which is given at a higher dose than the Pfizer-BioNTech shot, may cause certain types of heart inflammation at higher rates, primarily in younger males.
The CDC last week said more recent U.S. data showed that while there was a numerically higher rate of myocarditis or pericarditis with Moderna’s shot, the findings were not statistically significant, meaning they might be due to chance.
Data Points
A slew of studies and data has shown that children have the lowest COVID-19 mortality and hospitalization rates of any age group. Elderly people and immunocompromised individuals are the most at risk. In March, the CDC quietly removed about 25 percent of its recorded COVID-19 deaths among individuals younger than 18 as some doctors sounded the alarm about giving the vaccines to young children.In May of this year, Moderna submitted an application to the Food and Drug Administration (FDA) for children aged 6 to 11, who would get 50 micrograms, or half the dose given to adults.